Find a Doctor

Werner H. Poewe

Medical University Of Innsbruck
Male

Bio


Werner Poewe is in Innsbruck, Austria. They have been an author on 490 peer reviewed articles and participated in 2 clinical trials in the past 15 years.

Contact

Innsbruck, AT

Latest Advances


Latest Advance
Study
  • Condition: Multiple system atrophy
  • Journal: Parkinsonism & related disorders
  • Treatment Used: Physical therapy
  • Number of Patients: 20
  • Published —
The study researched the effect of physical therapy for treating multiple system atrophy.
Latest Advance
Study
  • Condition: Parkinson's Disease
  • Journal: Journal of Parkinson's disease
  • Treatment Used: Opicapone
  • Number of Patients: 1614
  • Published —
The study researched the safety and effectiveness of opicapone for patients with Parkinson's disease.
Latest Advance
Study
  • Condition: Parkinson's Disease
  • Journal: Journal of Parkinson's disease
  • Treatment Used: Levodopa-Carbidopa Intestinal Gel
  • Number of Patients: 356
  • Published —
In this study, researchers evaluated the safety and effectiveness of levodopa-carbidopa intestinal gel for the management of Parkinson's disease.
Latest Advance
Study
  • Condition: Multiple System Atrophy
  • Journal: The Lancet. Neurology
  • Treatment Used: epigallocatechin gallate
  • Number of Patients: 127
  • Published —
The purpose of the study was to establish if epigallocatechin gallate could safely slow disease progression in patients with multiple system atrophy.
Latest Advance
Study
  • Condition: Parkinson's Disease
  • Journal: European journal of neurology
  • Treatment Used: Opicapone
  • Number of Patients: 0
  • Published —
This study tested the safety and efficacy of using opicapone to treat patients with Parkinson's disease.
Latest Advance
Study
  • Condition: Tardive dystonia/dyskinesia
  • Journal: Brain stimulation
  • Treatment Used: Neurostimulation
  • Number of Patients: 25
  • Published —
This study evaluated the effects of neurostimulation in patients with tardive dystonia.
Latest Advance
Study
  • Condition: Cervical dystonia
  • Journal: European journal of neurology
  • Treatment Used: Liquid formulation of abobotulinumtoxinA (Dysport®)
  • Number of Patients: 369
  • Published —
The study researched quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport® ).
Latest Advance
Study
  • Condition: Parkinson's Disease with Persistent Motor Fluctuations
  • Journal: The Lancet. Neurology
  • Treatment Used: Apomorphine Subcutaneous Infusion
  • Number of Patients: 106
  • Published —
This study investigated the effectiveness and safety of apomorphine infusion compared with placebo in patients with Parkinson's disease with persistent motor fluctuations despite optimised oral or transdermal treatment.

Clinical Trials


Clinical Trial
  • Status: Recruiting
  • Participants: 4500
  • Start Date: July 1, 2020
The Parkinson's Progression Markers Initiative (PPMI) 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 48
  • Start Date: August 6, 2018
Nabilone for Non-motor Symptoms in Parkinson's Disease: An Open-label Study to Evaluate Long-term Safety and Efficacy

All Publications
View All


Publication
Study
  • Journal: Journal of Parkinson's disease
  • Published —
Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study.

Contact

Innsbruck, AT

Insurance

Contact them to find out if they accept your insurance plan.